Socialiya - Entertainment. Knowledge. Community.
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer

An international phase 3 clinical trial has found that an investigational oral medication (a daily p...

HEALTH NEWS June 04, 2026

Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer

An international phase 3 clinical trial has found that an investigational oral medication (a daily pill) doubled the median overall survival for patients...

3 views 0 likes 0 comments
Share:
An international phase 3 clinical trial has found that an investigational oral medication (a daily pill) doubled the median overall survival for patients...

Author: Harvard Medical School

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya